Skip to main content

Dr. Wu is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Wu's full profile

Already have an account?

  • Office

    200 UCLA Medical Plz Ste B265
    Los Angeles, CA 90095
    Phone+1 310-825-9775

Education & Training

  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Radiation Oncology, 2020 - 2024
  • Ohio State University College of Medicine
    Ohio State University College of MedicineClass of 2019
  • Ohio State University
    Ohio State UniversityBS, Biology, Cum Laude, 2010 - 2014

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2022 - 2026
  • OH State Medical License
    OH State Medical License 2019 - 2022

Awards, Honors, & Recognition

  • Undergraduate Recipient of The Provost Scholarship The Ohio State University, 2010-2014
  • Undergraduate Recipient of The American Society of Hematology Abstract Achievement Award American Society of Hematology, 2012

Publications & Presentations

PubMed

Journal Articles

  • Pre-Treatment Serum Bicarbonate Predicts for Primary Tumor Control after Stereotactic Body Radiation Therapy in Patients with Localized Non-Small Cell Lung Cancer.  
    Sebastian, N., Wu, T., Driscoll, E., Wilers, H., Musunuru, H., Mo, X., Tan, Y., Bazan, J., Haglund, K., Welliver, M., Baschnagel, A., Keane, F., Williams, T., Radiotherapy and Oncology, 5/2019
  • Pre-treatment Neutrophil-Lymphocyte Ratio is Associated with Overall Mortality in Localized Non-Small Cell Lung Cancer Treated with Stereotactic Body Radiotherapy  
    Wu, T., Sebastian, N., Bazan, J., Driscoll, E., Willers, H., Yegya-Raman, N., Bond, L., Dwivedi, A., Mo, X., Tan, Y., Welliver, M., Haglund, K., Jabbour, S., Keane, F...., Radiotherapy and Oncology
  • Complement Activation and Mortality During an Acute Episode of Thrombotic Thrombocytopenic Purpura  
    Wu, T., Yang, S., Haven S., Holers, V., Lundberg, A., Wu, H., Cataland, S., Journal of Thrombosis and Haemostasis, 8/2013

Abstracts/Posters

  • Pre-treatment Neutrophil-to-Lymphocyte ratio (NLR) is a Prognostic Biomarker for Overall Survival in Early Stage Non-Small Cell Lung Cancer Treated with Stereotactic B...
    Wu, T., Sebastian, N., Mo, X., Bazan, J., Welliver, M., Haglund, K., Williams, T., 2018 American Society for Radiation Oncology (ASTRO) Annual Meeting., San Antonio, TX, 10/2018

Other

  • Mortality From Thrombotic Thrombocytopenic Purpura is Related to Complement Hyperactivation Oral Presentation 
    Wu, T., Yang, S., Haven, S., Holers, V., Lundberg, A., Wu, H., Cataland, S.
    American Society of Hematology (ASH) Annual Meeting and Exposition; Atlanta, GA, USA. - 12/2012

Press Mentions

  • High-Dose Radiotherapy with Chemotherapy Effective in Treating People with Non-Small Cell Lung Cancer
    High-Dose Radiotherapy with Chemotherapy Effective in Treating People with Non-Small Cell Lung CancerJanuary 11th, 2024
  • Treatment Approach Effective When Surgery Not an Option for Lung Cancer
    Treatment Approach Effective When Surgery Not an Option for Lung CancerJanuary 14th, 2024

Professional Memberships

  • American Society for Radiation Oncology
    Member